Geode Capital Management LLC Has $43.64 Million Stake in STAAR Surgical (NASDAQ:STAA)

Geode Capital Management LLC grew its position in shares of STAAR Surgical (NASDAQ:STAA - Free Report) by 2.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,174,499 shares of the medical instruments supplier's stock after buying an additional 31,212 shares during the quarter. Geode Capital Management LLC owned approximately 2.38% of STAAR Surgical worth $43,641,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Arcadia Investment Management Corp MI acquired a new stake in shares of STAAR Surgical in the third quarter valued at $37,000. Quarry LP acquired a new stake in STAAR Surgical in the 3rd quarter valued at about $50,000. Canada Pension Plan Investment Board bought a new position in shares of STAAR Surgical in the second quarter worth about $129,000. Larson Financial Group LLC bought a new position in shares of STAAR Surgical in the second quarter worth about $130,000. Finally, Quest Partners LLC acquired a new position in shares of STAAR Surgical during the third quarter worth approximately $128,000. Institutional investors and hedge funds own 96.70% of the company's stock.

Insider Transactions at STAAR Surgical

In other news, major shareholder Broadwood Partners, L.P. purchased 23,000 shares of the firm's stock in a transaction dated Wednesday, December 18th. The stock was bought at an average price of $24.33 per share, with a total value of $559,590.00. Following the acquisition, the insider now directly owns 10,848,631 shares of the company's stock, valued at approximately $263,947,192.23. This represents a 0.21 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 1.00% of the company's stock.

STAAR Surgical Trading Up 3.3 %

Shares of NASDAQ:STAA traded up $0.80 during midday trading on Tuesday, hitting $24.97. The company had a trading volume of 210,119 shares, compared to its average volume of 702,364. STAAR Surgical has a 12 month low of $23.72 and a 12 month high of $52.68. The firm has a fifty day simple moving average of $27.85 and a 200 day simple moving average of $34.15. The stock has a market cap of $1.23 billion, a price-to-earnings ratio of 56.75 and a beta of 0.59.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on STAA. Canaccord Genuity Group dropped their price objective on shares of STAAR Surgical from $31.00 to $28.00 and set a "hold" rating for the company in a research report on Monday, December 9th. Needham & Company LLC restated a "hold" rating on shares of STAAR Surgical in a research report on Thursday, October 31st. Stephens raised STAAR Surgical to a "hold" rating in a research note on Monday, December 2nd. Finally, Stifel Nicolaus lowered their price objective on STAAR Surgical from $50.00 to $44.00 and set a "buy" rating for the company in a research report on Monday, August 26th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $42.83.

STAAR Surgical Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.